Sebastien Beauzile became the first person in NY to be made symptom-free after undergoing a new type of gene therapy.

Today, CASGEVY is approved for use in patients with sickle cell disease in the United States and multiple countries in Europe and the Middle East. “It’s an amazing gift to have been able to ...